薑黃素文獻薈萃報告 — 2026 年 3 月

摘要

本月共收錄 薑黃素 相關文獻 1503 篇,其中 Level 1 證據(Meta-Analysis/Systematic Review)83 篇,RCT 12 篇。

證據等級分布

證據等級 文獻數 佔比
Level 1 (Meta-Analysis/Systematic Review) 83 5.5%
Level 2 (RCT) 12 0.8%
Level 3 (Clinical Trial) 2 0.1%
Level 4 (Observational) 1 0.1%
Level 5 (Review/Case Report/Other) 1405 93.5%

功效分類統計

功效分類 中文 文獻數 佔比
immune 免疫調節 694 46.2%
other 其他 451 30.0%
metabolic 代謝 220 14.6%
cardiovascular 心血管 214 14.2%
digestive 消化 182 12.1%
cognitive 認知功能 171 11.4%
anti_aging 抗衰老 154 10.2%
musculoskeletal 肌肉骨骼 137 9.1%
skin 皮膚 105 7.0%
energy 活力 55 3.7%
sexual 性功能 24 1.6%

成分搭配統計

成分 文獻數
curcumin 1244
EPA 263
iron 211
turmeric 210
resveratrol 167
quercetin 107
stem cell 44
berberine 42
EGCG 39
hyaluronic acid 37

成分組合分析

以下列出最常被共同研究的成分組合:

成分組合 共同出現文獻數
EPA + curcumin 229
curcumin + iron 184
curcumin + resveratrol 166
curcumin + turmeric 116
curcumin + quercetin 106
quercetin + resveratrol 69
EPA + iron 50
curcumin + stem cell 42
berberine + curcumin 42
EPA + turmeric 37

成分功效分析

以下列出主要成分在各功效領域的研究文獻數:

成分 總文獻 免疫調節 其他 代謝 心血管 消化 抗衰老
curcumin 1244 624 333 192 188 156 131
EPA 263 124 68 43 46 36 32
iron 211 106 54 29 37 17 28
turmeric 210 87 72 43 33 25 17
resveratrol 167 118 22 40 38 27 37
quercetin 107 67 19 27 19 11 23
stem cell 44 22 15 1 3 1 3
berberine 42 31 8 12 6 8 8

研究類型分布

研究類型 文獻數 佔比
Meta-Analysis 44 2.9%
Systematic Review 39 2.6%
RCT 12 0.8%
Clinical Trial 2 0.1%
Observational 1 0.1%
Review 184 12.2%
Case Report 2 0.1%
Other 1219 81.1%

近期重要文獻

Level 1 證據(Meta-Analysis / Systematic Review)

  1. Research progress of curcumin and its derivatives as anti-inflammatory agents: From molecular mechanism to clinical application. — European journal of medicinal chemistry,
    • 功效分類:cognitive, immune
  2. Antidiabetic and Metabolic Effects of Turmeric (Curcuma Longa) in Patients with Type 2 Diabetes Mellitus or Hyperglycemia - A Systematic Meta-Review and Meta-Analysis. — Journal of Nepal Health Research Council,
    • 功效分類:anti_aging, cardiovascular, metabolic
  3. Levodopa and Plant-Derived Bioactive Compounds in Parkinson’s Disease: Mechanisms, Efficacy, and Future Perspectives. — CNS neuroscience & therapeutics, 2025-08-01
    • 功效分類:cognitive, immune, skin
  4. Analgesic Efficacy of Phytotherapeutic Agents in Dental Pain Management: A Systematic Review. — International journal of dentistry,
    • 功效分類:other
  5. Effectiveness of 0.1% triamcinolone acetonide compared with those of other therapies for minor recurrent aphthous stomatitis: a systematic review and meta-analysis of randomized controlled trials. — BMC oral health,
    • 功效分類:other

Level 2 證據(RCT)

  1. Effects of Maternal Curcumin Nano-Micelle Supplementation on Ewes and Their Offspring: Impact on Nutrient Digestibility, Ruminal Fermentation Parameters, Milk Composition and Metabolic Health During the Transition Period. — Journal of animal physiology and animal nutrition, 2025-11-01
    • 功效分類:cardiovascular, metabolic
  2. A Triple-blind randomized controlled trial on the effects of turmeric versus ginger on inflammatory biomarkers in patients with COVID-19. — Scientific reports, 2025-08-21
    • 功效分類:immune
  3. Anti-Inflammatory, Antithrombotic and Antioxidant Efficacy and Synergy of a High-Dose Vitamin C Supplement Enriched with a Low Dose of Bioflavonoids; In Vitro Assessment and In Vivo Evaluation Through a Clinical Study in Healthy Subjects. — Nutrients, 2025-08-14
    • 功效分類:cardiovascular, immune
  4. A randomized, placebo-controlled, crossover clinical trial to evaluate the effect of a turmeric formulation on muscle soreness and function recovery in moderately active adults. — Journal of the International Society of Sports Nutrition, 2025-12-01
    • 功效分類:immune, musculoskeletal
  5. The effectiveness and safety of nanocurcumin supplementation for diabetic peripheral neuropathy in patients with type 2 diabetes: a randomized double-blind clinical trial. — Nutrition journal, 2025-07-18
    • 功效分類:cardiovascular, immune, metabolic

免責聲明

本網站內容由 AI 自動生成,基於各國官方公開資料庫的產品登記資訊。 報告內容僅供參考,不構成醫療建議、投資建議或商業建議。 如有健康問題,請諮詢專業醫療人員。

產品統計以資料庫登記為準,不代表實際市場銷售狀況。 各國監管制度不同,跨國比較應考慮法規差異。


Copyright © 2026 保健食品產品情報系統

This site uses Just the Docs, a documentation theme for Jekyll.